When testing for group B Strep carriage, it’s important to do the right test.
Although the NHS does not routinely offer tests to all pregnant women for group B Strep, some women may be offered them. The two tests commonly used within the NHS to detect group B Strep carriage are:
- The standard ‘non-selective’ swab test, known as a High Vaginal Swab (HVS)
- The group B Strep-specific swab test, known as the Enriched Culture Medium (ECM) test
What’s the difference between the tests?
The standard ‘non-selective’ swab test (HVS)
This is a general-purpose test often used when a woman has vaginal symptoms, where the doctor or midwife wants to investigate further. This test involves taking samples, usually from high up in the vagina, using a swab and then processing these in a laboratory. It is not specifically designed to detect group B Strep bacteria and is not very good at doing so. It misses them.
A positive group B Strep result using this swab is highly reliable – there are very few false-positive results.
A negative group B Strep result using this swab is not reliable – this test gives a high proportion of false-negative results. This test only finds group B Strep about half the times it is present, so around half (50%) of those carrying group B Strep will be incorrectly told they are not
So a positive HVS test result can be trusted, but be wary of a negative one.
The group B Strep-specific swab test (ECM)
This test was specifically designed to detect group B Strep and is recommended by the Royal College of Obstetricians & Gynaecologists (RCOG) for women who carried GBS in their previous pregnancy. It’s increasingly available from NHS trusts, as well as privately (see here). It’s recognised internationally as the ‘Gold Standard’ test to use when detecting group B Strep carriage. This test involves taking samples from both the low vagina and rectum using one or more swabs, and then processing these in a laboratory.
Research has found that when the ECM test was properly performed within 5 weeks of delivery:
- A negative result was 96% predictive that a woman would not be carrying group B Strep at delivery (4% of women acquired GBS carriage between the test and giving birth)
- A positive result was 87% predictive that a woman would be carrying group B Strep at delivery (13% of women lost carriage between doing the test and giving birth)
This is why in other countries which of all pregnant women testing for group B Strep, the test is usually used, typically at 35-37 weeks of pregnancy.
A small group of women – those where they carried group B Strep in their previous pregnancy where their baby did not develop GBS infection – qualify to be offered an ECM test through the NHS.
Most pregnant women who want to test for group B Strep carriage will need to arrange this through a private supplier.
Other tests for GBS used during pregnancy
Urine tests are often offered during pregnancy. An initial dipstick test may signal that further investigation is needed, including for the presence of infection. At this point, a sample of urine may be sent off to the laboratory for culture.
Group B Strep may be found in a urine sample (it cannot be detected by a dipstick test). When cultured from a urine sample, depending on the level of bacteria found and whether the woman has symptoms, it may be that the woman has a group B Strep urinary tract infection (UTI) which will need treating with antibiotic tablets.
A negative urine test only means that group B Strep has not been found in the urine. It does not mean that group B Strep is not present in the vagina or rectum, which is where the large majority of the group B Strep bacteria is found.
Rapid or ‘bedside’ tests
Some research trials happening in the UK are looking at whether a rapid test, sometimes called a ‘bedside’ or ‘point-of-care’ test, is a good way of determining which women carry group B Strep. These tests take samples from both the low vagina and rectum using one or more swabs, which are then processed in a machine typically on the labour ward.
At present this sort of test is only used in the UK in clinical research trials.
If you have any questions about Group B Strep, please call our helpline
0330 120 0796
Or email us at firstname.lastname@example.org